Pro Chart

SANUWAVE Health Inc.

NasdaqGM: SNWV · Real-Time Price · USD
4.96
+0.22 (4.64%)
At close: Aug 17, 2026, 3:59 PM

SANUWAVE Health Inc. (SNWV) Stock Price, Analysis & Data

4.64%
Bid4.3
Market Cap42.67M
Revenue (ttm)44.02M
Net Income (ttm)15.26M
Beta1.50
EPS (ttm)0.85
PE Ratio (ttm)6.12
Forward PE-496
P/B (ttm)23.18
P/S (ttm)0.97
Earnings DateMay 15, 2017
Ask7.57
Volume108,445
Avg. Volume (20D)204,904
Open4.83
Previous Close4.74
Day's Range4.67 - 5.14
52-Week Range4.66 - 45.33
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About SNWV

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid...

Sector Healthcare
IPO Date Oct 18, 2024
Employees 55
Stock Exchange NasdaqGM
Ticker Symbol SNWV
Full Company Profile

Financial Performance

In 2025, SANUWAVE Health's revenue was 44.05M, an increase of 34.98% compared to the previous year's 32.63M. Earnings were 11.81M, a decrease of -135.71%.

Financial Statements

Earnings Surprise

SANUWAVE Health has released their quarterly earnings on Mar 26, 2026:
  • Revenue of $9.74M misses estimates by $0, with -3.13% YoY decline.
  • EPS of 0.03 misses estimates by -0.14, with 100.80% YoY growth.
  • SANUWAVE Health Inc. is scheduled to release its earnings on May 15, 2017, after market closes.
    Analysts project revenue of ... Upgrade